Modulation of toxin production by the flagellar regulon in Clostridium difficile

Infection and Immunity

Volumn 80, Issue 10, 2012, Pages 3521-3532

  Aubry, Annie ^a   Hussack, Greg ^a   Chen, Wangxue ^a   KuoLee, Rhonda ^a   Twine, Susan M ^a   Fulton, Kelly M ^a   Foote, Simon ^a   Carrillo, Catherine D ^b   Tanha, Jamshid ^a   Logan, Susan M ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CD0240 PROTEIN; FLHB PROTEIN; FLIC PROTEIN; FLIF PROTEIN; FLIM PROTEIN; FLIR PROTEIN; MUTANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLAGELLUM; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; IMMUNOASSAY; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEOMICS; REGULON; SUPERNATANT; TOXIN SYNTHESIS;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLAGELLA; GENE EXPRESSION REGULATION, BACTERIAL; MUTATION; PROTEOMICS; RNA, BACTERIAL; SIGMA FACTOR; TRANSCRIPTOME;

EID: 84867606653     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00224-12     Document Type: Article

References (50)

1. Akerlund T, Svenungsson BB, Lagergren A, Burman LG. 2006. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J. Clin. Microbiol. 44:353-358.
2. Ananthakrishnan AN. 2011. Clostridium difficile infection: epidemiology, risk factors and management. Nat. Rev. Gastroenterol. Hepatol. 8:17-26.
3. Antunes A, Martin-Verstraete I, Dupuy B. 2011. CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol. Microbiol. 79: 882-899.
4. Babcock GJ, et al. 2006. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters. Infect. Immun. 74:6339-6347.
5. Calabi E, Calabi F, Phillips AD, Fairweather NF. 2002. Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect. Immun. 70:5770-5778.
6. Canadian Council on Animal Care. 1993. Guide to the care and use of experimental animals. Canadian Council on Animal Care, Ottawa, ON, Canada.
7. Carter GP, Rood JI, Lyras D. 2012. The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol. 20:21-29.
8. Chaves-Olarte E, Weidmann M, Eichel-Streiber C, Thelestam M. 1997. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells. J. Clin. Invest. 100:1734-1741.
9. Chevance FF, Hughes KT. 2008. Coordinating assembly of a bacterial macromolecular machine. Nat. Rev. Microbiol. 6:455-465.
10. Cozy LM, Kearns DB. 2010. Gene position in a long operon governs motility development in Bacillus subtilis. Mol. Microbiol. 76:273-285.
11. Dineen SS, Villapakkam AC, Nordman JT, Sonenshein AL. 2007. Repression of Clostridium difficile toxin gene expression by CodY. Mol. Microbiol. 66:206-219.
12. Dingle TC, Mulvey GL, Armstrong GD. 2011. Mutagenic analysis of the Clostridium difficile flagellar proteins, FliC and FliD, and their contribution to virulence in hamsters. Infect. Immun. 79:4061-4067.
13. Dupuy B, Sonenshein AL. 1998. Regulated transcription of Clostridium difficile toxin genes. Mol. Microbiol. 27:107-120.
14. Eaton KA, Morgan DR, Krakowka S. 1992. Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori. J. Med. Microbiol. 37:123-127.
15. Fulton KM, et al. 2011. Immunoproteomic analysis of the human antibody response to natural tularemia infection with type A or type B strains or LVS vaccination. Int. J. Med. Microbiol. 301:591-601.
16. Gardel CL, Mekalanos JJ. 1996. Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression. Infect. Immun. 64:2246-2255.
17. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM. 1999. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20:601-605.
18. Govind R, Dupuy B. 2012 Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog. 8:e1002727. doi: 10.1371/journal.ppat.1002727.
19. Heap JT, Cartman ST, Kuehne SA, Cooksley C, Minton NP. 2010. ClosTron-targeted mutagenesis. Methods Mol. Biol. 646:165-182.
20. Heap JT, et al. 2010. The ClosTron: mutagenesis in Clostridium refined and streamlined. J. Microbiol. Methods 80:49-55.
21. Hundsberger T, et al. 1997. Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur. J. Biochem. 244:735-742.
22. Hussack G, et al. 2011. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain. J. Biol. Chem. 286:8961-8976.
23. Ishihama Y, et al. 2005. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 4:1265-1272.
24. Konkel ME, et al. 2004. Secretion of virulence proteins from Campylobacter jejuni is dependent on a functional flagellar export apparatus. J. Bacteriol. 186:3296-3303.
25. Lee AS, Song KP. 2005. LuxS/autoinducer-2 quorum sensing molecule regulates transcriptional virulence gene expression in Clostridium difficile. Biochem. Biophys. Res. Commun. 335:659-666.
26. Liu Z, et al. 2008. Mucosal penetration primes Vibrio cholerae for host colonization by repressing quorum sensing. Proc. Natl. Acad. Sci. U. S. A. 105:9769-9774.
27. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
28. Macnab RM. 1999. The bacterial flagellum: reversible rotary propellor and type III export apparatus. J. Bacteriol. 181:7149-7153.
29. Mani N, Dupuy B. 2001. Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc. Natl. Acad. Sci. U. S. A. 98:5844-5849.
30. Matamouros S, England P, Dupuy B. 2007. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol. Microbiol. 64: 1274-1288.
31. Metcalf D, Sharif S, Weese JS. 2010. Evaluation of candidate reference genes in Clostridium difficile for gene expression normalization. Anaerobe 16:439-443.
32. Mirel DB, Chamberlin MJ. 1989. The Bacillus subtilis flagellin gene (hag) is transcribed by the sigma 28 form of RNA polymerase. J. Bacteriol. 171: 3095-3101.
33. Olling A, et al. 2012. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene. Microb. Pathog. 52:92-100.
34. Razaq N, et al. 2007. Infection of hamsters with historical and epidemic BI types of Clostridium difficile. J. Infect. Dis. 196:1813-1819.
35. Richardson K. 1991. Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models. Infect. Immun. 59:2727-2736.
36. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 7:526-536.
37. Saujet L, Monot M, Dupuy B, Soutourina O, Martin-Verstraete I. 2011. The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. J. Bacteriol. 193:3186-3196.
38. Silva AJ, Benitez JA. 2006. A Vibrio cholerae relaxed (relA) mutant expresses major virulence factors, exhibits biofilm formation and motility, and colonizes the suckling mouse intestine. J. Bacteriol. 188: 794-800.
39. Stabler RA, et al. 2009. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 10:R102. doi:10.1186/gb-2009-10-9-r102.
40. Syed KA, et al. 2009. The Vibrio cholerae flagellar regulatory hierarchy controls expression of virulence factors. J. Bacteriol. 191:6555-6570.
41. Tsou AM, Frey EM, Hsiao A, Liu Z, Zhu J. 2008. Coordinated regulation of virulence by quorum sensing and motility pathways during the initial stages of Vibrio cholerae infection. Commun. Integr. Biol. 1:42-44.
42. Twine SM, et al. 2009. Motility and flagellar glycosylation in Clostridium difficile. J. Bacteriol. 191:7050-7062.
43. Underwood S, et al. 2009. Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J. Bacteriol. 191:7296-7305.
44. Voth DE, Ballard JD. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247-263.
45. Warny M, et al. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084.
46. West JT, Estacio W, Marquez-Magana L. 2000. Relative roles of the fla/che P(A), P(D-3), and P(sigD) promoters in regulating motility and sigD expression in Bacillus subtilis. J. Bacteriol. 182:4841-4848.
47. Wroblewski D, et al. 2009. Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens. J. Clin. Microbiol. 47:2142-2148.
48. Yao R, et al. 1994. Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: the role of motility in adherence and invasion of eukaryotic cells. Mol. Microbiol. 14:883-893.
49. Yu NY, et al. 2010. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26:1608-1615.
50. Zhou M, Boekhorst J, Francke C, Siezen RJ. 2008. LocateP: genomescale subcellular-location predictor for bacterial proteins. BMC Bioinformatics 9:173. doi:10.1186/1471-2105-9-173.